These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A quality by design (QbD) study on enoxaparin sodium loaded polymeric microspheres for colon-specific delivery. Hales D; Vlase L; Porav SA; Bodoki A; Barbu-Tudoran L; Achim M; Tomuță I Eur J Pharm Sci; 2017 Mar; 100():249-261. PubMed ID: 28088371 [TBL] [Abstract][Full Text] [Related]
9. Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology. Agrawal G; Wakte P; Shelke S Endocr Metab Immune Disord Drug Targets; 2017; 17(2):149-165. PubMed ID: 28472911 [TBL] [Abstract][Full Text] [Related]
10. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers. Dewangan HK; Pandey T; Maurya L; Singh S Int J Biol Macromol; 2018 May; 111():804-812. PubMed ID: 29343454 [TBL] [Abstract][Full Text] [Related]
11. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers. Ma Y; Coombes AG J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007 [TBL] [Abstract][Full Text] [Related]
12. Molecular Evaluation of Oral Immunogenicity of Hepatitis B Antigen Delivered by Hydrogel Microparticles. Chen XY; Butt AM; Mohd Amin MCI Mol Pharm; 2019 Sep; 16(9):3853-3872. PubMed ID: 31398038 [TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity. Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810 [TBL] [Abstract][Full Text] [Related]
14. HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay. Rezaei M; Hosseini SN; Khavari-Nejad RA; Najafi F; Mahdavi M Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1543-1558. PubMed ID: 31007088 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation. Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733 [TBL] [Abstract][Full Text] [Related]
17. Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox. Beyer S; Moosmann A; Kahnt AS; Ulshöfer T; Parnham MJ; Ferreirós N; Wagner S; Wacker MG Pharm Res; 2015 Dec; 32(12):3986-98. PubMed ID: 26216175 [TBL] [Abstract][Full Text] [Related]
18. Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles. Mouftah S; Abdel-Mottaleb MMA; Lamprecht A Int J Pharm; 2016 Dec; 515(1-2):565-574. PubMed ID: 27773855 [TBL] [Abstract][Full Text] [Related]
19. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Kola Srinivas NS; Verma R; Pai Kulyadi G; Kumar L Int J Nanomedicine; 2017; 12():15-28. PubMed ID: 28031710 [TBL] [Abstract][Full Text] [Related]
20. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery. Qindeel M; Ahmed N; Sabir F; Khan S; Ur-Rehman A Drug Dev Ind Pharm; 2019 Apr; 45(4):629-641. PubMed ID: 30633578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]